Anxiety Induced by Repetitive Transcranial Magnetic Stimulation is Suppressed by Chronic Treatment of Paroxetine in Rats

Repetitive transcranial magnetic stimulation (rTMS) has been shown to have a therapeutic effect on affective disorder and anxiety disorders. However, some reports have linked rTMS to a significant increase in anxiety in normal volunteers. This study investigates the effect of rTMS on anxiety and the use of acute and chronic paroxetine treatment on this animal model of anxiety. In normal rats, rTMS for 10 days induced anxiety, as shown by elevated plus maze, black and white box, and conditioned fear tests. This anxiety was suppressed by chronic, but not acute, paroxetine. These results suggest that rats receiving chronic rTMS treatment can be used as a model of anxiety and that the anxiety induced by rTMS might involve the serotonergic system.

Key words

Transcranial magnetic stimulation - anxiety - paroxetine - rats - chronic treatment - serotonin

References

• 1 Baldwin D, Bobes J, Stein D J, Scharwachter I, Faure M. Paroxetine in social phobia/social anxiety disorder. Randomized, double-blind, placebo-controlled study. Paroxetine Study Group.  Br J Psychiatry. 1999;  175 120-126
• 2 Barker A T. An introduction to the basic principles of magnetic nerve stimulation.  J Clin Neurophysiology. 1991;  8 26-37
• 3 Belmaker R H, Fleischmann A. Transcranial magnetic stimulation: a potential new frontier in psychiatry.  Biol Psychiatry. 1995;  38 419-421
• 4 Ben-Shachar D, Gazawi H, Riboyad-Levin J, Klein E. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain.  Brain Res. 1999;  816 78-83
• 5 Feinsod M, Kreinin B, Chistyakov A, Klein E. Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia.  Depress Anxiety. 1998;  7 65-68
• 6 Fujiki M, Steward O. High frequency transcranial magnetic stimulation mimics the effect of ECS in upregulating astoglial gene expression in the murine CNS.  Mol Brain Res. 1997;  44 301-308
• 7 Gates J R. Transcranial magnetic stimulation.  Neuroimaging Clin N Am. 1995;  5 711-720
• 8 George M S, Wassermann E M, Williams W A, Callahan A, Ketter T A, Basser P, Hallett M, Post R M. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression.  Neuroreport. 1995;  6 1853-1856
• 9 George M S, Wassermann E M, Post R M. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century.  J Neuropsychiatry Clin Neurosci. 1996;  8 373-382
• 10 George M S, Ketter T A, Kimbrell T A, Speer AM,Lorberbaum J, Liberaatos C C, Nahas Z, Post R M. Neuroimaging approaches to the study of emotion. In Borod JC, editor The Neuropsychogy of Emotion New York; 2000: 123-124
• 11 Greenberg B D, George M S, Martin J D, Benjamin J, Schlaepfer T E, Altemus M, Wassermann E M, Post R M, Murphy D L. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study.  Am J Psychiatry. 1997;  154 867-869
• 12 Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker R H. Transcranial magnetic stimulation in mania: a controlled study.  Am J Psychiatry. 1998;  155 1608-1610
• 13 Hausmann A, Weis C, Marksteiner J, Hinterhuber H, Humpel C. Chronic repetitive transcranial magnetic stimulation enhances c-fos in the parietal cortex and hippocampus.  Mol Brain Res. 2000;  76 355-362
• 14 Ji R R, Schlaepfer T E, Aizenman C D, Epstein C M, Qiu D, Huang J C, Rupp F. Repetitive transcranial magnetic stimulation activates specific regions in rat brain.  Proc Natl Acad Sci USA.. 1998;  95 15 635-15 640
• 15 Kole M H, Fuchs E, Ziemann U, Paulus W, Ebert U. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats.  Brain Res. 1999;  826 309-312
• 16 Lydiard R B, Steiner M, Burnham D, Gergel I. Efficacy studies of paroxetine in panic disorder.  Psychopharmacol Bull. 1998;  34 175-182
• 17 Marshall R D, Schneier F R, Fallon B A, Knight C B, Abbate L A, Goetz D, Campeas R, Liebowitz M R. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.  J Clin Psychopharmacol. 1998;  18 10-18
• 18 Martin J D, George M S, Greenberg B D, Wassermann E M, Schlaepfer T E, Murphy D L, Hallette M, Post R M. Mood effects of prefrontal repetitive high frequency transcranial magnetic stimulation in healthy volunteers.  CNS Spectrum. 1997;  2 53-68
• 19 McCann U D, Kimbrell T A, Morgan C M, Anderson T, Geraci M, Benson B E, Wassermann E M, Willis M W, Post R M. Repetitive transcranial magnetic stimulation for posttraumatic stress disorder.  Arch Gen Psychiatry. 1998;  55 276-279
• 20 Pascual-Leone A, Rubio B, Pallardo F, Catala M D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.  Lancet. 1996;  348 233-237
• 21 Perrault G, Morel E, Zivkovic B, Sanger D J. Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice.  Pharmacol Biochem Behav. 1992;  42 45-47
• 22 Pigott T A, Seay S M. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.  J Clin Psychiatry. 1999;  60 101-106
• 23 Shimada A, Yamaguchi K, Naito H, Narita H, Nishioka Y. Influence of paroxetine on aggressive behavior in raphe-lesioned or olfactory-bulbectomized rats.  Preclin Rep Cent Inst Exp Amim. 1996;  20 163-167
• 24 Tulloch I F, Johnson A M. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.  J Clin Psychiatry. 1992;  53 Suppl 7-12